NO20082915L - Sulfamoylsulfonat-prodrug - Google Patents
Sulfamoylsulfonat-prodrugInfo
- Publication number
- NO20082915L NO20082915L NO20082915A NO20082915A NO20082915L NO 20082915 L NO20082915 L NO 20082915L NO 20082915 A NO20082915 A NO 20082915A NO 20082915 A NO20082915 A NO 20082915A NO 20082915 L NO20082915 L NO 20082915L
- Authority
- NO
- Norway
- Prior art keywords
- sulfamoylsulfonat
- prodrug
- compounds
- sulfamoylsulfonate
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Oppfinnelsen angår sulfamoylsulfonat-prodrug med generell formel (I), en fremgangsmåte for fremstilling av slike, farmasøytiske preparater som inneholder disse forbindelser, og anvendelse av dem for fremstilling av oralt tilgjengelige legemidler. Forbindelsene ifølge oppfinnelsen binder seg til karboanhydraser og inhiberer disse enzymer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005057408A DE102005057408A1 (de) | 2005-11-30 | 2005-11-30 | Sulfamoylsulfonat-Prodrugs |
PCT/EP2006/011726 WO2007062874A2 (de) | 2005-11-30 | 2006-11-27 | Sulfamoylsulfonat-prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082915L true NO20082915L (no) | 2008-06-27 |
Family
ID=37983623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082915A NO20082915L (no) | 2005-11-30 | 2008-06-27 | Sulfamoylsulfonat-prodrug |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1957513A2 (no) |
JP (1) | JP2009517424A (no) |
KR (1) | KR20080072956A (no) |
CN (1) | CN101316858A (no) |
AU (1) | AU2006319380A1 (no) |
BR (1) | BRPI0619253A2 (no) |
CA (1) | CA2632272A1 (no) |
CR (1) | CR10003A (no) |
DE (1) | DE102005057408A1 (no) |
EA (1) | EA200801306A1 (no) |
EC (1) | ECSP088489A (no) |
IL (1) | IL191570A0 (no) |
NO (1) | NO20082915L (no) |
WO (1) | WO2007062874A2 (no) |
ZA (1) | ZA200805659B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2411003A4 (en) * | 2009-03-24 | 2012-10-17 | Univ Singapore | USE OF ARTEMISININE DERIVATIVES IN THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE BRONCHO-PNEUMOPATHY (COPD) |
CN101987104A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物 |
CN101987101A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
DE102004025986A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
-
2005
- 2005-11-30 DE DE102005057408A patent/DE102005057408A1/de not_active Ceased
-
2006
- 2006-11-27 WO PCT/EP2006/011726 patent/WO2007062874A2/de active Application Filing
- 2006-11-27 AU AU2006319380A patent/AU2006319380A1/en not_active Abandoned
- 2006-11-27 KR KR1020087015775A patent/KR20080072956A/ko not_active Application Discontinuation
- 2006-11-27 JP JP2008542678A patent/JP2009517424A/ja active Pending
- 2006-11-27 CN CNA2006800449086A patent/CN101316858A/zh active Pending
- 2006-11-27 EP EP06829354A patent/EP1957513A2/de not_active Withdrawn
- 2006-11-27 BR BRPI0619253-0A patent/BRPI0619253A2/pt not_active Application Discontinuation
- 2006-11-27 CA CA002632272A patent/CA2632272A1/en not_active Abandoned
- 2006-11-27 EA EA200801306A patent/EA200801306A1/xx unknown
-
2008
- 2008-05-20 IL IL191570A patent/IL191570A0/en unknown
- 2008-05-21 CR CR10003A patent/CR10003A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008489A patent/ECSP088489A/es unknown
- 2008-06-27 ZA ZA200805659A patent/ZA200805659B/xx unknown
- 2008-06-27 NO NO20082915A patent/NO20082915L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006319380A1 (en) | 2007-06-07 |
CA2632272A1 (en) | 2007-06-07 |
CN101316858A (zh) | 2008-12-03 |
JP2009517424A (ja) | 2009-04-30 |
WO2007062874A2 (de) | 2007-06-07 |
IL191570A0 (en) | 2008-12-29 |
CR10003A (es) | 2008-08-21 |
BRPI0619253A2 (pt) | 2011-09-27 |
KR20080072956A (ko) | 2008-08-07 |
ECSP088489A (es) | 2008-06-30 |
DE102005057408A1 (de) | 2007-05-31 |
EP1957513A2 (de) | 2008-08-20 |
EA200801306A1 (ru) | 2008-10-30 |
WO2007062874A3 (de) | 2007-07-12 |
ZA200805659B (en) | 2009-10-28 |
WO2007062874B1 (de) | 2007-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090295L (no) | Substituerte heteroarylderivater | |
TW200800999A (en) | Novel compounds | |
NO20090628L (no) | Pyridizinon derivativater | |
TW200745114A (en) | Novel compounds | |
NO20084256L (no) | DPP IV inhibitorformuleringer | |
NO20091603L (no) | Kjemiske forbindelser | |
TW200745084A (en) | Novel compounds | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
NO20065936L (no) | Sulfonyletylfosfordiamidater for anvendelse ved behandling av cancer. | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
NO20081160L (no) | Benzimidazoltiofen forbindelser | |
NO20070570L (no) | Forbindelser. | |
DK2036892T3 (da) | 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
TW200635916A (en) | Compounds | |
MY150497A (en) | New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them | |
NO20073631L (no) | Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel | |
WO2009013545A3 (en) | Chemical compounds | |
NO20091935L (no) | Nye krystalliske former | |
DK1670778T3 (da) | Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende | |
NO20082915L (no) | Sulfamoylsulfonat-prodrug | |
NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |